Related Experiment Video
Updated: Mar 8, 2026
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections
Matteo Bassetti1, Alessia Carnelutti, Elda Righi
1Infectious Diseases Division, Santa Maria Misericordia Hospital, Udine, Italy.
Purpose Of Review:
Methicillin-resistant Staphylococcus aureus (MRSA) has become a major public health issue worldwide over the last years. MRSA is frequently implicated in the development of skin and soft tissue infections, leading to significant increases in morbidity, mortality and overall healthcare costs.
Recent Findings:
In order to face the threat of MRSA, major changes in clinical management of skin and soft tissue infections are required. The identification of populations at risk for the acquisition of infections due to MRSA, together with the improvement of the diagnostic techniques, is paramount. Moreover, a number of new antimicrobials with activity against MRSA have been recently developed and approved for the treatment of skin and soft tissue infections, however, the use of the new drugs in the wide clinical practice remains limited.
Summary:
We reviewed the current epidemiology of MRSA in skin and soft tissue infections, with particular focus on implications for clinical management. The potential role of new antibiotic options against MRSA infections is also discussed.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) causes significant public health issues, particularly skin infections. New treatments are emerging, but their clinical use is limited, necessitating improved diagnostics and risk identification.
Area of Science:
- Infectious Diseases
- Public Health
- Clinical Microbiology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a growing global health concern.
- MRSA infections, especially skin and soft tissue infections (SSTIs), increase morbidity, mortality, and healthcare expenses.
Purpose of the Study:
- To review the current epidemiology of MRSA in SSTIs.
- To discuss implications for clinical management of MRSA SSTIs.
- To explore the role of novel antibiotic options for MRSA infections.
Main Methods:
- Literature review of current MRSA epidemiology.
- Analysis of clinical management strategies for MRSA SSTIs.
- Evaluation of new antimicrobial agents for MRSA.
Main Results:
- MRSA poses a significant threat, requiring changes in clinical management of SSTIs.
- Identifying at-risk populations and improving diagnostic techniques are crucial.
- New MRSA antimicrobials exist but have limited clinical uptake.
Conclusions:
- Effective management of MRSA SSTIs requires updated epidemiological insights.
- Enhanced diagnostics and risk stratification are essential for controlling MRSA.
- Further research and implementation strategies are needed to optimize the use of new antibiotics against MRSA.
Related Concept Videos
01:23Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:31Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
01:18Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
01:30Development of Antibiotic Resistance
01:36Mismatch Repair
01:27Combined Effects of Drugs: Synergism
Such synergistic combinations...